Published in Nucl Med Commun on July 01, 2005
Heat shock protein-derived T-cell epitopes contribute to autoimmune inflammation in pediatric Crohn's disease. PLoS One (2009) 0.83
Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study. Am J Gastroenterol (2016) 0.77
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
A large retrospective single-centre study to define the best image acquisition protocols and interpretation criteria for white blood cell scintigraphy with ⁹⁹mTc-HMPAO-labelled leucocytes in musculoskeletal infections. Eur J Nucl Med Mol Imaging (2013) 2.04
99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur J Nucl Med Mol Imaging (2005) 1.51
Platelet count/spleen diameter ratio for non-invasive diagnosis of oesophageal varices: is it useful in compensated cirrhosis? Dig Liver Dis (2012) 1.46
Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist. Inflamm Bowel Dis (2007) 1.46
EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med (2013) 1.37
Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci (2002) 1.28
Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging (2010) 1.27
99mTc-besilesomab (Scintimun) in peripheral osteomyelitis: comparison with 99mTc-labelled white blood cells. Eur J Nucl Med Mol Imaging (2011) 1.26
MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology (2005) 1.23
Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy. J Clin Virol (2008) 1.13
The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol (2013) 1.13
Comment on Aksoy et al.: FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection. Eur J Nucl Med Mol Imaging (2014) 1.09
PET/MRI in infectious and inflammatory diseases: will it be a useful improvement? Eur J Nucl Med Mol Imaging (2012) 1.08
Time for radiobiology in the nuclear medicine community. Eur J Nucl Med Mol Imaging (2011) 1.07
Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections. Int J Infect Dis (2010) 1.05
FDG-PET/CT in infections: the imaging method of choice? Eur J Nucl Med Mol Imaging (2010) 1.03
Small intestine contrast ultrasonography: an alternative to radiology in the assessment of small bowel disease. Inflamm Bowel Dis (2005) 1.03
Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med (2004) 1.02
Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl Med Commun (2006) 0.98
Imaging of β-cell mass and insulitis in insulin-dependent (Type 1) diabetes mellitus. Endocr Rev (2012) 0.98
Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med (2012) 0.98
Early treatment in Crohn's disease: do we have enough evidence to reverse the therapeutic pyramid? J Gastrointestin Liver Dis (2012) 0.98
Adalimumab in active ulcerative colitis: a "real-life" observational study. Dig Liver Dis (2013) 0.98
Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging (2010) 0.98
CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid (2005) 0.97
Leukocyte and bacteria imaging in prosthetic joint infection. Eur Cell Mater (2013) 0.96
New frontiers of MRI in Crohn's disease: motility imaging, diffusion-weighted imaging, perfusion MRI, MR spectroscopy, molecular imaging, and hybrid imaging (PET/MRI). Abdom Imaging (2012) 0.96
Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab. Arthritis Rheum (2005) 0.95
Nuclear medicine imaging of bone infections. Nucl Med Commun (2006) 0.93
In vivo biodistribution of stem cells using molecular nuclear medicine imaging. J Cell Physiol (2011) 0.93
Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot? J Nucl Med (2011) 0.90
99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease. Eur J Nucl Med Mol Imaging (2003) 0.89
Tumour angiogenesis pathways: related clinical issues and implications for nuclear medicine imaging. Eur J Nucl Med Mol Imaging (2002) 0.89
Low bioavailability and traditional systemic steroids in IBD: can the former take over the latter? J Gastrointestin Liver Dis (2013) 0.88
Nuclear medicine imaging of inflammatory/infective disorders of the abdomen. Nucl Med Commun (2005) 0.87
Imaging of cell trafficking in Crohn's disease. J Cell Physiol (2010) 0.86
Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging (2007) 0.86
99mTc-EDDA/HYNIC-TOC in the management of medullary thyroid carcinoma. Cancer Biother Radiopharm (2004) 0.86
Image acquisition and interpretation criteria for 99mTc-HMPAO-labelled white blood cell scintigraphy: results of a multicentre study. Eur J Nucl Med Mol Imaging (2013) 0.85
Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck. Cancer Biother Radiopharm (2008) 0.85
Monthly and seasonal birth patterns and the occurrence of Crohn's disease. Am J Gastroenterol (2009) 0.84
Self-reported milk intolerance in irritable bowel syndrome: what should we believe? Clin Nutr (2004) 0.84
Oral beclomethasone dipropionate as an alternative to systemic steroids in mild to moderate ulcerative colitis not responding to aminosalicylates. Dig Dis Sci (2009) 0.84
11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreas. J Nucl Med (2012) 0.84
N-(4-18F-fluorobenzoyl)interleukin-2 for PET of human-activated T lymphocytes. J Nucl Med (2012) 0.84
Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy. J Nucl Med (2006) 0.84
Synthesis and optimization of the labeling procedure of 99mTc-HYNIC-interleukin-2 for in vivo imaging of activated T lymphocytes. Mol Imaging Biol (2009) 0.83
Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis. J Crohns Colitis (2011) 0.83
High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma. Tumori (2005) 0.83
Biological therapies for rheumatoid arthritis: progress to date. BioDrugs (2013) 0.83
Ferritin as a simple indicator of iron deficiency in anemic IBD patients. Inflamm Bowel Dis (2006) 0.83
In vivo and in vitro evidence that ⁹⁹mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery. Eur J Nucl Med Mol Imaging (2014) 0.82
Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception. Inflamm Bowel Dis (2008) 0.82
(123)I-Interleukin-2 uptake in squamous cell carcinoma of the head and neck carcinoma. Eur J Nucl Med Mol Imaging (2007) 0.82
Fever of unknown origin, infection of subcutaneous devices, brain abscesses and endocarditis. Nucl Med Commun (2006) 0.82
Methotrexate-induced pneumonitis in a patient with Crohn's disease. J Crohns Colitis (2010) 0.81
Molecular imaging in atherosclerosis. Eur J Nucl Med Mol Imaging (2010) 0.81
MRI in the evaluation of facial dermal fillers in normal and complicated cases. Eur Radiol (2014) 0.81
18-fluorodeoxyglucose positron emission tomography in nonendocrine neoplastic disorders of the gastrointestinal tract. Gastroenterology (2003) 0.81
Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3. PLoS One (2008) 0.81
GI distension in severe ulcerative colitis. Am J Gastroenterol (2002) 0.81
Radiolabeled annexin-V for monitoring treatment response in oncology. Cancer Biother Radiopharm (2004) 0.81
In favour of early surgery in Crohn's disease: a hypothesis to be tested. J Crohns Colitis (2010) 0.81
Synthesis and evaluation of 99mTc-labelled monoclonal antibody 1D09C3 for molecular imaging of major histocompatibility complex class II protein expression. Mol Imaging Biol (2011) 0.80
The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study. J Clin Apher (2011) 0.80
A study on QT interval in patients affected with inflammatory bowel disease without cardiac involvement. Intern Emerg Med (2010) 0.80
Natalizumab in the treatment of Crohn's disease. Biologics (2008) 0.80
Biological agents for ulcerative colitis: hypes and hopes. Med Res Rev (2008) 0.80
Radiolabelled probes targeting infection and inflammation for personalized medicine. Curr Pharm Des (2014) 0.79
Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literature. Multidiscip Respir Med (2010) 0.79
Smad3 knock-out mice as a useful model to study intestinal fibrogenesis. World J Gastroenterol (2006) 0.79
Differences in the location and activity of intestinal Crohn's disease lesions between adult and paediatric patients detected with MRI. Eur Radiol (2012) 0.79
Annexin V detection of lipopolysaccharide-induced cardiac apoptosis. Shock (2007) 0.79
IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies. Dig Liver Dis (2009) 0.79
Medical therapy for Crohn's disease: top-down or step-up? Dig Dis (2007) 0.79
Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's disease. Curr Clin Pharmacol (2012) 0.78
Synthesis of 99mTc-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes. Eur J Nucl Med Mol Imaging (2006) 0.78
Pharmacokinetic modelling of N-(4-[(18)F]fluorobenzoyl)interleukin-2 binding to activated lymphocytes in an xenograft model of inflammation. Eur J Nucl Med Mol Imaging (2012) 0.78
Nuclear medicine imaging for prediction or early assessment of response to chemotherapy in patients suffering from breast carcinoma. Breast Cancer Res Treat (2002) 0.78
Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck. Nucl Med Commun (2008) 0.77
Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs. J Nucl Med (2006) 0.77
Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis. World J Gastroenterol (2011) 0.77
Mesenteric adenitis caused by Yersinia pseudotubercolosis in a patient subsequently diagnosed with Crohn's disease of the terminal ileum. World J Gastroenterol (2006) 0.77
Diagnosis of vascular prosthesis infection: PET or SPECT? J Nucl Med (2007) 0.77
Investigation of 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide. Nucl Med Biol (2010) 0.77
Randomized controlled trials in prevention of postsurgical recurrence in Crohn's disease. Rev Recent Clin Trials (2012) 0.76
Introduction to the feature section on "Crohn's disease activity: MRI assessment and clinical implications". Abdom Imaging (2012) 0.76
Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes. J Nucl Med (2009) 0.76
(99m)Tc-labeled-rhTSH analogue (TR1401) for imaging poorly differentiated metastatic thyroid cancer. Thyroid (2014) 0.76
Radioiodinated recombinant human TSH: a novel radiopharmaceutical for thyroid cancer metastases detection. Cancer Biother Radiopharm (2004) 0.76
In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy. Nucl Med Biol (2005) 0.76
Late-breaking news from the "4th International Meeting on Inflammatory Bowel Diseases" Capri, 2006. Inflamm Bowel Dis (2007) 0.76
Reply to comment by Koranda: 99mTc-HMPAO-labelled leucocytes in musculoskeletal infections--the choice of reference tissue for a semiquantitative analysis. Eur J Nucl Med Mol Imaging (2014) 0.75
Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases. Inflamm Bowel Dis (2007) 0.75
Development of fistulae in ileo-anal pouch does not necessarily indicate Crohn's disease. Am J Gastroenterol (2004) 0.75
Clinical course of late-onset Crohn's disease. Inflamm Bowel Dis (2009) 0.75